← Research ProtocolsDelta Sleep-Inducing Peptide (DSIP)
STUDIED EXPOSURE MAP / 1981
Delta Sleep-Inducing Peptide (DSIP)
tested in research.
The actual doses, concentrations or exposure levels reported by the source — kept attached to route, population, timeframe and evidence type.
HUMAN / SMALL CLINICAL TRIALEUROPEAN NEUROLOGYSTUDIED EXPOSURE ≠ RECOMMENDED DOSE
STUDIED EXPOSURE / SOURCE DATANumbers below describe this research source only.
25 nmol/kg
single IV administration
Context: This was a very small, older human study. The exposure is shown for historical research context, not as evidence of established efficacy or a recommended sleep protocol.
NOT A DOSING GUIDEENHANCED is reporting what researchers administered or tested. It does not convert these numbers into a personal dose, reconstitution plan, cycle, titration schedule or recommendation.
SOURCE / EUROPEAN NEUROLOGY
The influence of synthetic DSIP on disturbed human sleep
Study design and tested exposure are separated from recommendation. Route and population stay visible so the numbers cannot be read without context.
1981
01 / DESIGNSmall acute clinical sleep study
02 / POPULATION / MODEL6 middle-aged chronic insomniacs
03 / ROUTEIntravenous
04 / TIMEFRAMEAcute single-administration study
05 / PRIMARY QUESTIONSleep behaviour after administration
It supports a factual statement about the exposure tested in this research source. It does not establish that the same exposure is appropriate, effective or safe outside that source.
Delta sleep-inducing peptide research
Study exposure ≠ personal protocol. Animal doses are never converted to human-equivalent amounts here. IV, topical, oral, intranasal and subcutaneous exposures are not treated as interchangeable.